Dec 6, 2025 3:00:00 PM
Comparison of automated vs manual extraction of NSAIDs from plasma using ISOLUTE® SLE+
By Biotage
Introduction
Automated sample preparation using the Biotage® Extrahera™ was compared to an equivalent manual method utilizing a vacuum manifold. A selection of non-steroidal anti-inflammatory drugs (NSAIDS) were extracted from pooled stripped plasma using a supported liquid extraction procedure. ISOLUTE® SLE+ 400 µL sample volume plates, part number 820-0400-P01 were used for extraction.
Resulting extracts from both sample preparation methods were subsequently analysed by LC-MS/MS.
Procedure
A pooled plasma sample was prepared in a sufficient quantity to run a full 96-well plate for each processing method. This pooled plasma sample was fortified with Sulindac, Ketoprofen and Indomethacin at a concentration of 25 ng/mL respectively.
From this pooled plasma sample 250 µL was transferred to all wells of two 96-well plates.
All subsequent aspects of sample preparation were performed in duplicate on two separate plates utilizing either Extrahera™ or manual preparation using a calibrated air-displacement pipette.
The pooled plasma sample was pre-treated 1:1 (v/v) with 1 % formic acid (250 µL). This sample dilution results in approximate loading pH of 3.2.
After pre-wetting the pipette tips via aspirate/dispense cycling and to mix the samples; 400 µL of the pre-treated sample was loaded to each well of the ISOLUTE® SLE+ plates. Flows were initiated using a pulse of positive pressure (Extrahera™) or vacuum (manual method).
After leaving for 5 minutes to allow the sample to completely absorb into the plates, elution was performed by the application of 2 x 0.9 mL aliquots of methyl tertiary-butyl ether (MTBE) to the ISOLUTE® SLE+ plates. The extracts were collected in 2 mL 96-well collection plates under gravity elution, and as a final step to recover all available solvent from the media, by applying a pulse of positive pressure (Extrahera™) or vacuum (manual method). The extracts were evaporated to dryness in a TurboVap® 96 at 37 °C and reconstituted in 200 µL of 60:40 (v/v) water/methanol solution. The plates were mixed on an orbital shaker for 10 minutes.
HPLC conditions
Instrument: Waters Alliance 2795
Cartridge: ACE Excel 2 C18-AR 50 x 2.1mm id cartridge
Mobile Phase: 50:50 (v/v) 0.1 % (v/v) formic acid/acetonitrile at 0.25 mL/min
Injection Volume: 25 µL
Mass spectrometry
Instrument: Waters Quattro Ultima Pt
MRM Conditions
|
Analyte |
Transition |
RT (min) |
Dwell (sec) |
Cone (V) |
Col Energy (V) |
|
Indomethacin |
358.1 to 139.0 |
2.5 |
0.1 |
35 |
18 |
|
Sulindac |
357.1 to 233.1 |
0.9 |
0.1 |
35 |
26 |
|
Ketoprofen |
255.1 to 209.1 |
1.2 |
0.1 |
35 |
13 |
Experimental precautions
- Both plates were evaporated side by side on the same evaporation instrument (TurboVap® 96).
- During analysis on the LC-MS system samples were injected alternately from the two plates to reduce the effect of any sample stability issues.
- The same batch/bottles of samples, reagents and solvents were used for both methods.
Results
Average peak area data was calculated for all three compounds to compare any improvements in analyte recovery between Biotage® Extrahera™ and manually processed samples.
Peak area ratio data was also generated for all samples by referencing the analyte vs. Ketoprofen. This provides standardized data to allow a comparison of the % RSD of the Extrahera vs. manual data sets.
|
|
Extrahera Sulindac Peak Area Ratio Summary |
Manual Sulindac Peak Area Ratio Summary |
|
Average Sulindac Peak Area |
24622 |
22847 |
|
Improvement (%) vs. Manual Method |
7.8 |
- |
|
|
|
|
|
Average IS Peak Area |
35199 |
32683 |
|
Improvement (%) vs. Manual Method |
7.7 |
- |
|
|
|
|
|
Average Peak Area Ratio |
0.701 |
0.705 |
|
% RSD of Extrahera™ Extraction |
4.01 |
6.43 |
|
Improvement (%) vs. Manual Method |
37.6 |
- |
|
|
|
|
|
|
Extrahera Indomethacin Peak Area Ratio Summary |
Manual Indomethacin Peak Area Ratio Summary |
|
Average Indomethacin Peak Area |
34395 |
27965 |
|
Improvement (%) vs. Manual Method |
23.0 |
- |
|
|
|
|
|
Average IS Peak Area |
35199 |
32683 |
|
Improvement (%) vs. Manual Method |
7.7 |
- |
|
|
|
|
|
Average Peak Area Ratio |
0.977 |
0.857 |
|
% RSD of Extrahera™ Extraction |
5.46 |
8.56 |
|
Improvement (%) vs. Manual Method |
36.2 |
- |
Conclusion
A significant reduction to the % RSD was measured when using the Biotage® Extrahera™ for both compounds compared to the manual processing approach.
|
% RSD |
Manual Procedure (n=96) |
Extrahera (n=96) |
|
Sulindac |
6.43 |
4.01 |
|
Indomethacin |
8.56 |
5.46 |
For Sulindac the % RSD improved by 37%, for Indomethacin there was also an improvement in the % RSD by 36 % to 5.46%. The results also suggest that methods performed on the Extrahera™ could give higher recoveries due to increases in the absolute average peak areas
|
|
Manual Procedure (n=96) |
Extrahera (n=96) |
|
Sulindac |
22847 |
24622 |
|
Indomethacin |
27965 |
34395 |
Both compounds returned average peak areas that were higher when sample extraction was performed using Extrahera™ than the manual method with an average peak area increase of 15.4%. The greatest improvement was measured with Indomethacin where the average peak area was increased by 23%.
Literature number: PPS361
Published: Dec 6, 2025 3:00:00 PM